ArticleBone marrow transplantation2026

Relapse risk after FLAMSA RIC based allogeneic hematopoietic stem cell transplantation in heavily pretreated AML patients.

Jule Ussmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.